Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 14 studies | 22% ± 7% | |
| brain | 11 studies | 35% ± 18% | |
| lung | 9 studies | 27% ± 9% | |
| intestine | 5 studies | 22% ± 6% | |
| eye | 5 studies | 27% ± 6% | |
| heart | 5 studies | 28% ± 9% | |
| adipose | 4 studies | 21% ± 2% | |
| bone marrow | 3 studies | 18% ± 1% | |
| liver | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 99% | 13587.07 | 1429 / 1445 | 100% | 24.36 | 183 / 183 |
| brain | 99% | 6074.93 | 2615 / 2642 | 100% | 32.90 | 704 / 705 |
| prostate | 100% | 5938.96 | 244 / 245 | 99% | 28.99 | 497 / 502 |
| lung | 100% | 9248.52 | 576 / 578 | 98% | 19.20 | 1127 / 1155 |
| intestine | 100% | 7912.64 | 965 / 966 | 97% | 16.42 | 510 / 527 |
| breast | 98% | 6916.38 | 450 / 459 | 97% | 25.43 | 1084 / 1118 |
| thymus | 97% | 3897.41 | 633 / 653 | 97% | 21.27 | 588 / 605 |
| uterus | 99% | 6825.23 | 169 / 170 | 94% | 17.23 | 432 / 459 |
| skin | 94% | 6232.31 | 1701 / 1809 | 99% | 117.47 | 466 / 472 |
| stomach | 94% | 5045.51 | 337 / 359 | 97% | 19.05 | 277 / 286 |
| adrenal gland | 98% | 5074.06 | 254 / 258 | 90% | 13.21 | 206 / 230 |
| bladder | 100% | 7075.29 | 21 / 21 | 87% | 12.87 | 436 / 504 |
| kidney | 91% | 3196.34 | 81 / 89 | 92% | 20.13 | 831 / 901 |
| ovary | 100% | 5187.13 | 180 / 180 | 82% | 10.07 | 351 / 430 |
| pancreas | 58% | 1708.21 | 191 / 328 | 95% | 15.02 | 169 / 178 |
| eye | 0% | 0 | 0 / 0 | 100% | 135.28 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.95 | 29 / 29 |
| muscle | 100% | 84468.55 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5904.79 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 7935.64 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7468.90 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 33269.14 | 850 / 861 | 0% | 0 | 0 / 0 |
| liver | 35% | 958.84 | 78 / 226 | 64% | 6.27 | 258 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 20.63 | 42 / 45 |
| peripheral blood | 76% | 5199.25 | 706 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008286 | Biological process | insulin receptor signaling pathway |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0017124 | Molecular function | SH3 domain binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | ZNF106 |
| Protein name | Zinc finger protein 106 Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474) |
| Synonyms | ZFP106 ZNF474 hCG_40432 SH3BP3 |
| Description | FUNCTION: RNA-binding protein. Specifically binds to 5'-GGGGCC-3' sequence repeats in RNA. Essential for maintenance of peripheral motor neuron and skeletal muscle function. Required for normal expression and/or alternative splicing of a number of genes in spinal cord and skeletal muscle, including the neurite outgrowth inhibitor RTN4. Also contributes to normal mitochondrial respiratory function in motor neurons, via an unknown mechanism. . |
| Accessions | ENST00000263805.8 [Q9H2Y7-1] H3BNX5 ENST00000564754.7 H3BS99 ENST00000565380.5 [Q9H2Y7-2] ENST00000567041.1 ENST00000565948.1 ENST00000567772.2 ENST00000565611.5 Q9H2Y7 H3BSS6 A0A0C4DGM5 U3KQH7 H3BRD4 ENST00000565500.5 H3BNJ4 ENST00000569648.5 |